StockData
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31

Lumexa Imaging Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$10.72−0.06 (-0.56%)

Close on Oct 19, 2026

Market cap
$1.03B
P/E (TTM)
–
Dividend yield
–

Lumexa Imaging Holdings, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Lumexa Imaging does not break out revenue by segment, region or product in the tagged data of its filings for this period type.